SUNESIS PHARMACEUTICALS INC (34) | Business Finance (13)

Browse by Subcategory

Recent Contracts

Loan and Security Agreement, dated November 4, 2021, by and among Viracta Therapeutics, Inc., Viracta Subsidiary, Inc., Silicon Valley Bank and Oxford Finance LLC (Filed With SEC on November 10, 2021)
Royalty Purchase Agreement by and between the Registrant and XOMA (US) LLC, dated March 22, 2021 (Filed With SEC on May 13, 2021)
Description of Capital Stock (Filed With SEC on February 24, 2021)
Underwriting Agreement relating to the Offering, dated July 29, 2020 (Filed With SEC on July 31, 2020)
First Amendment to Loan and Security Agreement between Viracta Subsidiary, Inc. and Silicon Valley Bank, dated as of May 27, 2021 (Filed With SEC on May 28, 2021)
Description of Capital Stock (Filed With SEC on May 7, 2020)
Underwriting Agreement relating to the Common Stock Offering, dated July 10, 2019 (Filed With SEC on July 12, 2019)
Underwriting Agreement relating to the Series F Offering, dated July 10, 2019 (Filed With SEC on July 12, 2019)
Form of Specimen Series F Preferred Stock Certificate (Filed With SEC on July 12, 2019)
Term Loan Agreement, dated April 26, 2019, by and between Sunesis Pharmaceuticals, Inc. and Silicon Valley Bank (Filed With SEC on April 29, 2019)
Underwriting Agreement relating to the Common Stock Offering, dated January 17, 2019 (Filed With SEC on January 22, 2019)
Underwriting Agreement relating to the Series E Offering, dated January 17, 2019 (Filed With SEC on January 22, 2019)
Form of Specimen Series E Preferred Stock Certificate (Filed With SEC on January 22, 2019)